Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Anti-inflammatory Therapy in Diabetic Macular Edema
NCT00900887Phase 2Completed
- Sponsor
- Hospital Juárez de México
- Start
- Apr 2008
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in diabetic macular edema (DME) comparing Ketorolac, Nepafenac and Placebo (3 arms). Primary endpoint: Ocular Topic Antiinflammatory Therapy Application at 1 week. Started Apr 2008; status: completed.
02
Drugs
ketorolac tromethaminenepafenac
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00900887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00900887.